Spartalis, M.; Kasimatis, E.; Liakou, E.; Sampani, E.; Lioulios, G.; Christodoulou, M.; Stai, S.; Moysidou, E.; Efstratiadis, G.; Papagianni, A.
Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis. Life 2023, 13, 454.
https://doi.org/10.3390/life13020454
AMA Style
Spartalis M, Kasimatis E, Liakou E, Sampani E, Lioulios G, Christodoulou M, Stai S, Moysidou E, Efstratiadis G, Papagianni A.
Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis. Life. 2023; 13(2):454.
https://doi.org/10.3390/life13020454
Chicago/Turabian Style
Spartalis, Michalis, Efstratios Kasimatis, Eleni Liakou, Erasmia Sampani, Georgios Lioulios, Michalis Christodoulou, Stamatia Stai, Eleni Moysidou, George Efstratiadis, and Aikaterini Papagianni.
2023. "Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis" Life 13, no. 2: 454.
https://doi.org/10.3390/life13020454
APA Style
Spartalis, M., Kasimatis, E., Liakou, E., Sampani, E., Lioulios, G., Christodoulou, M., Stai, S., Moysidou, E., Efstratiadis, G., & Papagianni, A.
(2023). Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis. Life, 13(2), 454.
https://doi.org/10.3390/life13020454
